Surgical challenge of massive bilateral staghorn renal calculi in a spinal cord injury patientM M Issa
Palo Alto Veterans Affairs Medical Center, Palo Alto, Calif, USA
Urol Int 61:247-50. 1998
..Furthermore, the importance of treating bladder dysfunction and urinary metabolic abnormalities is emphasized...
Comparative analysis of alpha-blocker utilization in combination with 5-alpha reductase inhibitors for enlarged prostate in a managed care setting among Medicare-aged menMuta M Issa
Department of Urology, Emory University, 1670 Clairmont Rd, Decatur, GA 30033, USA
Am J Manag Care 14:S160-6. 2008
..To evaluate the likelihood of alpha-adrenergic antagonist (alpha-blocker) discontinuation in combination with dutasteride or finasteride among patients aged > or =65 years with enlarged prostate...
Medical and minimally invasive therapies for the treatment of benign prostatic hyperplasiaR C Harkaway
Residency Training Urology, Albert Einstein Medical Center, Philadelphia, PA 19141, USA
Prostate Cancer Prostatic Dis 9:204-14. 2006
..The initial choice for any given patient will depend on his presenting circumstances and the influence of treatment risks on these circumstances. Providing patients with informed treatment decisions is a key element of management...
The effect of urethral instrumentation on uroflowmetryM M Issa
Department of Urology, Emory University School of Medicine, and Atlanta Veterans Affairs Medical Center, Atlanta, Georgia 30322, USA
BJU Int 92:426-8. 2003
..To evaluate in a prospective study the effect of urethral instrumentation (flexible cystoscopy) on uroflowmetry, and in particular the peak urinary flow rate (Qmax)...
Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the Department of Veterans Affairs Cooperative Study TrialTheodore M Johnson
Birmingham/Atlanta GRECC, Atlanta VA Medical Center, 16780 Clairmont Road, Decatur, GA 30033, USA
J Urol 170:145-8. 2003
..3 nocturia episode. For a person to reach a 50% or greater reduction in nocturia, the advantage of terazosin over placebo was 17 percentage points. Changes in nocturia had a moderate impact on symptom specific quality of life measures...
Medical therapy for benign prostatic hyperplasia--present and future impactMuta M Issa
Emory University School of Medicine, Atlanta, GA 30322, USA
Am J Manag Care 13:S4-9. 2007
..Although the information presented does not prove superiority of either product, it will answer some important questions and raise some important issues beyond ingredient cost...
A large retrospective analysis of acute urinary retention and prostate-related surgery in BPH patients treated with 5-alpha reductase inhibitors: dutasteride versus finasterideMuta M Issa
Emory University School of Medicine, Atlanta, GA 30322, USA
Am J Manag Care 13:S10-6. 2007
..This study constitutes the first direct comparison of therapeutic outcome between a mono 5ARI (finasteride) and a dual 5ARI (dutasteride)...
5alpha-reductase inhibition for men with enlarged prostateMuta M Issa
Department of Urology, Emory University School of Medicine AVAMC 112, Atlanta, Georgia 30033, USA
J Am Acad Nurse Pract 19:398-407. 2007
..This article reviews the use of alpha-blockers and 5alpha-reductase inhibitors (5ARIs) in the management of LUTS and enlarged prostate...
Dilutional hyponatremia of TURP syndrome: a historical event in the 21st centuryMuta M Issa
Department of Urology, Atlanta Veterans Affairs Medical Center, Decatur, Georgia, USA
Urology 64:298-301. 2004
..In addition, the system permits the faculty to spend the time needed for teaching and training urology residents without compromising patient safety...
Clinical and economic outcomes in patients treated for enlarged prostateMichael James Naslund
Applied Health Outcomes, 4114 Woodlands Parkway, Suite 500, Palm Harbor, FL 34685, USA
Am J Manag Care 12:S111-6. 2006
..CONCLUSION: Patients receiving 5-alpha reductase inhibitor therapy alone were less likely to have AUR compared with patients receiving alpha blockers and tended to be less likely to have surgery (P = .054)...